BioCentury | Jan 6, 2014
Company News

Cyprotex, North American Science Associates deal

...On Jan. 2, CRO Cyprotex acquired NAMSA's CeeTox Inc. division for about £630,000 ($1 million) in...
...for the year ended Sept. 30, 2013, and an operating loss of £900,000 ($1.4 million). Cyprotex plc...
BioCentury | Sep 9, 2013
Financial News

Cyprotex proposes private placement of notes

Cyprotex plc (LSE:CRX), Macclesfield, U.K. Business: ADMET Date announced: Type: Private placement of notes To be raised: Up to £7 million ($10.9 million) Shares outstanding prior: 224.3 million Investor: Hardwood Capital Note: Hardwood Capital agreed...
BioCentury | Feb 25, 2013
Company News

Axion Biosystems, Cyprotex sales and marketing update

...is available on Axion's high-throughput Maestro MEA drug screening system. Axion Biosystems , Atlanta, Ga. Cyprotex plc...
BioCentury | Nov 5, 2012
Company News

Cyprotex, Pfizer deal

...18-month deal to improve Cyprotex's predictive toxicology ADMET services. The companies did not disclose details. Cyprotex plc...
BioCentury | Oct 22, 2012
Company News

Cyprotex, Sigma-Aldrich sales and marketing update

...Sigma Aldrich's Sigma Life Science business granted Cyprotex a non-exclusive license to offer Sigma's transporter knockout...
...screening and safety studies. The assays were developed using CompoZr Zinc Finger Nuclease (ZFN) technology. Cyprotex...
...ATP-binding cassette sub-family C member 2 transporters. The companies could not be reached for details. Cyprotex plc...
BioCentury | Oct 1, 2012
Company News

Cyprotex sales and marketing update

...Preclinical CRO Cyprotex launched the CellCiphr Premier service for classifying cellular responses to drug exposure. The...
...toxicity markers from replicating and metabolically competent cells to identify early and late stage toxicities. Cyprotex plc...
BioCentury | Apr 2, 2012
Company News

Cyprotex, Sygnature Discovery sales and marketing update

...medicinal chemistry and Cyportex's ADME/PK services. Details were not disclosed (see BioCentury, Dec. 14, 2009). Cyprotex plc...
BioCentury | Oct 10, 2011
Company News

Cyprotex sales and marketing update

...launched its gADME service worldwide to determine the effect of genetic polymorphisms on drug pharmacokinetics. Cyprotex plc...
BioCentury | Apr 26, 2010
Company News

Cyprotex management update

Cyprotex plc (LSE:CRX), Macclesfield, U.K. Business: ADMET Hired: Ben Butterfield as executive director for business development in North America, formerly business development manager at Toxikon Corp. WIR Staff...
BioCentury | Dec 14, 2009
Company News

Cyprotex, Sygnature Chemical Services Ltd. sales and marketing update

...Cyprotex's Cyprotex Discovery Ltd. subsidiary and Sygnature entered into an agreement to provide a discovery chemistry/...
...to provide a discovery chemistry/ DMPK service using Sygnature's medicinal chemistry and Cyprotex's ADME/PK services. Cyprotex plc...
Items per page:
1 - 10 of 48
BioCentury | Jan 6, 2014
Company News

Cyprotex, North American Science Associates deal

...On Jan. 2, CRO Cyprotex acquired NAMSA's CeeTox Inc. division for about £630,000 ($1 million) in...
...for the year ended Sept. 30, 2013, and an operating loss of £900,000 ($1.4 million). Cyprotex plc...
BioCentury | Sep 9, 2013
Financial News

Cyprotex proposes private placement of notes

Cyprotex plc (LSE:CRX), Macclesfield, U.K. Business: ADMET Date announced: Type: Private placement of notes To be raised: Up to £7 million ($10.9 million) Shares outstanding prior: 224.3 million Investor: Hardwood Capital Note: Hardwood Capital agreed...
BioCentury | Feb 25, 2013
Company News

Axion Biosystems, Cyprotex sales and marketing update

...is available on Axion's high-throughput Maestro MEA drug screening system. Axion Biosystems , Atlanta, Ga. Cyprotex plc...
BioCentury | Nov 5, 2012
Company News

Cyprotex, Pfizer deal

...18-month deal to improve Cyprotex's predictive toxicology ADMET services. The companies did not disclose details. Cyprotex plc...
BioCentury | Oct 22, 2012
Company News

Cyprotex, Sigma-Aldrich sales and marketing update

...Sigma Aldrich's Sigma Life Science business granted Cyprotex a non-exclusive license to offer Sigma's transporter knockout...
...screening and safety studies. The assays were developed using CompoZr Zinc Finger Nuclease (ZFN) technology. Cyprotex...
...ATP-binding cassette sub-family C member 2 transporters. The companies could not be reached for details. Cyprotex plc...
BioCentury | Oct 1, 2012
Company News

Cyprotex sales and marketing update

...Preclinical CRO Cyprotex launched the CellCiphr Premier service for classifying cellular responses to drug exposure. The...
...toxicity markers from replicating and metabolically competent cells to identify early and late stage toxicities. Cyprotex plc...
BioCentury | Apr 2, 2012
Company News

Cyprotex, Sygnature Discovery sales and marketing update

...medicinal chemistry and Cyportex's ADME/PK services. Details were not disclosed (see BioCentury, Dec. 14, 2009). Cyprotex plc...
BioCentury | Oct 10, 2011
Company News

Cyprotex sales and marketing update

...launched its gADME service worldwide to determine the effect of genetic polymorphisms on drug pharmacokinetics. Cyprotex plc...
BioCentury | Apr 26, 2010
Company News

Cyprotex management update

Cyprotex plc (LSE:CRX), Macclesfield, U.K. Business: ADMET Hired: Ben Butterfield as executive director for business development in North America, formerly business development manager at Toxikon Corp. WIR Staff...
BioCentury | Dec 14, 2009
Company News

Cyprotex, Sygnature Chemical Services Ltd. sales and marketing update

...Cyprotex's Cyprotex Discovery Ltd. subsidiary and Sygnature entered into an agreement to provide a discovery chemistry/...
...to provide a discovery chemistry/ DMPK service using Sygnature's medicinal chemistry and Cyprotex's ADME/PK services. Cyprotex plc...
Items per page:
1 - 10 of 48